A detailed history of Clear Street Markets LLC transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Clear Street Markets LLC holds 133 shares of PLRX stock, worth $180. This represents 0.0% of its overall portfolio holdings.

Number of Shares
133
Holding current value
$180
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

BUY
$1.35 - $13.53 $179 - $1,799
133 New
133 $0
Q2 2024

Jul 26, 2024

BUY
$10.58 - $15.61 $58,528 - $86,354
5,532 New
5,532 $59,000

Others Institutions Holding PLRX

About PLIANT THERAPEUTICS, INC.


  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $66.2M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Clear Street Markets LLC Portfolio

Follow Clear Street Markets LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Street Markets LLC with notifications on news.